Síndrome de malabsorción refractario al régimen sin gluten: linfoma intestinal de tipo mediterráneo o inmunoproliferativo?

Parrochia, Esteban; Silva, Mireya C; Vela, Hamilton.
Bol. Hosp. San Juan de Dios ; 32(1): 63-6, ene.-feb. 1985.
Artículo en Español | LILACS | ID: lil-2157

Documentos relacionados

  1. Management of Locally Advanced and Unresectable Small Bowel Neuroendocrine Tumours.
  2. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
  3. Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update.
  4. [Difficulties and challenges in pathological diagnosis of gastrointestinal pancreatic neuroendocrine tumors].
  5. [A Case of Small Intestinal Cancer Resected by Laparoscopic Surgery].
  6. [Patient with Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma with Small Intestinal Perforation Development during Chemotherapy].
  7. Chemotherapy in NEN: still has a role?
  8. Progress in the Treatment of Small Intestine Cancer.
  9. [<sup>177</sup>Lu]Lu-DOTA-TATE plus long-acting octreotide versus high­dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.
  10. <sup>68</sup> Ga-DOTATATE Positron Emission Tomography-Computed Tomography Quantification Predicts Response to Somatostatin Analog Therapy in Gastroenteropancreatic Neuroendocrine Tumors.